IT8249251A0 - Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo - Google Patents

Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo

Info

Publication number
IT8249251A0
IT8249251A0 IT8249251A IT4925182A IT8249251A0 IT 8249251 A0 IT8249251 A0 IT 8249251A0 IT 8249251 A IT8249251 A IT 8249251A IT 4925182 A IT4925182 A IT 4925182A IT 8249251 A0 IT8249251 A0 IT 8249251A0
Authority
IT
Italy
Prior art keywords
production
pharmaceutical use
enzymatic procedure
indolpyruvic acid
indolpyruvic
Prior art date
Application number
IT8249251A
Other languages
English (en)
Other versions
IT1148618B (it
Inventor
Mario Materazzi
Giovanna De Luca
Giovanni Di Stazio
Vincenzo Politi
Original Assignee
Polifarma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polifarma Spa filed Critical Polifarma Spa
Priority to IT49251/82A priority Critical patent/IT1148618B/it
Publication of IT8249251A0 publication Critical patent/IT8249251A0/it
Priority to DE8383830196T priority patent/DE3378742D1/de
Priority to US06/540,051 priority patent/US4551471A/en
Priority to EP83830196A priority patent/EP0106813B1/en
Priority to JP58189782A priority patent/JPS5995894A/ja
Application granted granted Critical
Publication of IT1148618B publication Critical patent/IT1148618B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
IT49251/82A 1982-10-11 1982-10-11 Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo IT1148618B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT49251/82A IT1148618B (it) 1982-10-11 1982-10-11 Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
DE8383830196T DE3378742D1 (de) 1982-10-11 1983-10-07 Pharmaceutical utilisation of 3-indolpyruvic acid
US06/540,051 US4551471A (en) 1982-10-11 1983-10-07 Use of 3-indolepyruvic acid for increasing serotonin
EP83830196A EP0106813B1 (en) 1982-10-11 1983-10-07 Pharmaceutical utilisation of 3-indolpyruvic acid
JP58189782A JPS5995894A (ja) 1982-10-11 1983-10-11 医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49251/82A IT1148618B (it) 1982-10-11 1982-10-11 Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo

Publications (2)

Publication Number Publication Date
IT8249251A0 true IT8249251A0 (it) 1982-10-11
IT1148618B IT1148618B (it) 1986-12-03

Family

ID=11270097

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49251/82A IT1148618B (it) 1982-10-11 1982-10-11 Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo

Country Status (5)

Country Link
US (1) US4551471A (it)
EP (1) EP0106813B1 (it)
JP (1) JPS5995894A (it)
DE (1) DE3378742D1 (it)
IT (1) IT1148618B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1184282B (it) * 1985-06-28 1987-10-22 Polifarma Spa Procedimento per la produzione di alfa-chetoacidi indolici a partire da un rispettivo alfa-ammino-acido,particolarmente per produrre acido indolpiruvico
US4639465A (en) * 1985-08-30 1987-01-27 Commonwealth Medical Corporation Of America Method and composition for relieving pain
US4650789A (en) * 1985-10-15 1987-03-17 Commonwealth Medical Corporation Of America Method and composition for increasing production of serotonin
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
IT1206078B (it) * 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
US4831156A (en) * 1987-09-30 1989-05-16 The University Of Tennessee Research Corp. 3-substituted 2-alkyl indole derivatives
IT1224546B (it) * 1988-09-29 1990-10-04 Polifarma Spa Utilizzatore farmaceutica di acido 3 -indolpiruvico come agente inibitore di patologie degenerative
IT1232167B (it) * 1989-08-08 1992-01-25 Polifarma Spa Uso cosmetico di acido 3-indolpiruvico
IT218019Z2 (it) * 1989-09-08 1992-03-05 Enea Dispositivo protettivo individuale, portatile ad isolamento totale conatmosfera controllata
IT1237472B (it) * 1989-10-04 1993-06-07 Polifarma Spa Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
IT1261165B (it) * 1993-01-25 1996-05-09 Polifarma Spa Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'.
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
ATE497013T1 (de) 2001-12-27 2011-02-15 Ajinomoto Kk Verfahren zur herstellung von glutaminsäurederivaten
US7297800B2 (en) 2001-12-27 2007-11-20 Ajinomoto Co., Inc. Process of producing glutamate derivatives
CN103525847A (zh) 2002-08-26 2014-01-22 味之素株式会社 新型醛缩酶和取代α-酮酸的制备方法
KR100723826B1 (ko) 2002-12-09 2007-06-04 아지노모토 가부시키가이샤 변이형 d-아미노트랜스퍼라제 및 이를 사용하는 광학활성글루탐산 유도체의 제조방법
US7180370B2 (en) * 2004-09-01 2007-02-20 Micron Technology, Inc. CMOS amplifiers with frequency compensating capacitors
CN102027117B (zh) 2007-08-24 2012-11-07 味之素株式会社 新的氧化酶基因及使用该基因生产3-吲哚-丙酮酸的方法
JPWO2012050125A1 (ja) 2010-10-14 2014-02-24 味の素株式会社 モナティンの製造方法
WO2020012373A1 (en) * 2018-07-10 2020-01-16 Polindols S.R.L.S. New drugs chronic invalidating pathologies and to slow aging, based on a new metabolic tryptophan route and production process thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals

Also Published As

Publication number Publication date
IT1148618B (it) 1986-12-03
EP0106813A3 (en) 1986-05-07
DE3378742D1 (de) 1989-02-02
JPS5995894A (ja) 1984-06-02
US4551471A (en) 1985-11-05
EP0106813B1 (en) 1988-12-28
EP0106813A2 (en) 1984-04-25

Similar Documents

Publication Publication Date Title
ES549929A0 (es) Procedimiento para la produccion de acido tereftalico
IT1148618B (it) Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
IT1150686B (it) Procedimento per la produzione di acido tereftalico
ES536502A0 (es) Procedimiento para la fabricacion de acido 7beta-(carboxialquenoilamino)-3-cefem-4-carboxilico
IT1190018B (it) Procedimento per la produzione di beta-allumina
IT8348479A0 (it) Procedimento ed apparecchio per laproduzione di acido solforico
IT1158015B (it) Procedimento per la produzione di acido 6-idrossi-2-naftoico
IT1201435B (it) Procedimento per la produzione di alchil trifluracetati
ES549070A0 (es) Procedimiento para la preparacion de cianamidas de acido 2-fenoxipropionico.
IT1211546B (it) Procedimento per la produzione di acido piromellitico
IT1132076B (it) Procedimento per la produzione di acido cloridico ed amoniaca
IT1179031B (it) Procedimento per la produzione di tirosina
IT1180208B (it) Procedimento per la produzione di beta-fenilserina
MX156980A (es) Procedimiento para la produccion de acido p-nitrotoluen-2-sulfonico
IT1170545B (it) Procedimento per la produzione di acidi amminociclopentanoici
IT1141971B (it) Procedimento per la produzione di acido fluoridrico
ES545068A0 (es) Procedimiento para la fabricacion de derivados del acido aminotiazolilpropandicarboxilico
IT1191210B (it) Procedimento per la preparazione di esteri dell acido alcossivincaminico e di esteri dell acido alcossia povincaminico
AR240801A1 (es) Procedimiento para la produccion de acido 4-nitrotoluen-2-sulfonico
IT1164613B (it) Procedimento per la produzione di ditiazol-disolfuri
IT1171888B (it) Procedimento per la produzione di acciaio inossidabile
IT1193836B (it) Procedimento per la produzione di acido 6-d-alfa-amino-p-idrossifenilacetamido enicillanico
IT1152277B (it) Procedimento per la produzione di acido clavulanico
IT8149591A0 (it) Procedimento per la produzione di acido 6-idrossi-2-naftoico
IT8222835A0 (it) Isoneri di amminoacidi eprocedimento per la loro produzione.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971021